Table 2

Molecular mass of immunoprecipitated TTR (Da, mean ± SD) assigned to different forms1 of TTR between serum and ascitic fluid of 20 representative women with ovarian cancer. Values in brackets represent mass differences of modified TTR in relationship to the native form of TTR (Da, mean ± SD).

TTR

cysTTR

cysglycTTR

glutTTR


serum

13757.7 ± 7.1

13875.8 ± 12.8 (118.1 ± 13.7)

13923.6 ± 21.0 (166.8 ± 20.9)

14062.1 ± 24.7 (306.4 ± 23.9)

ascitic fluid

13752.7 ± 16.5

13876.9 ± 13.3 (124.2 ± 13.7)

13926.8 ± 11.1 (176.8 ± 1.8)

14042.5 ± 27.0 (294.6 ± 22.7)


1 TTR = native TTR; cysTTR = TTR + cysteinylation; cysglycTTR = TTR + cysteinylglycine; glutTTR = TTR + glutathione; no significant differences between molecular masses of serum and ascitic fluid could be observed

Gericke et al. BMC Cancer 2005 5:133   doi:10.1186/1471-2407-5-133

Open Data